Revenue, 2025
USD 402.49 Bn
Forecast Year, 2034
USD 771.67 Bn
CAGR, 2025 - 2034
7.50%
Report Coverage
Worldwide
The global endomyocardial biopsy market, valued at USD 402.49 million in 2025, is projected to reach USD 771.67 million by 2034, expanding at a CAGR of 7.5%, driven by rising cardiovascular disease prevalence and advancements in cardiac diagnostics.
Endomyocardial Biopsy Market Size Analysis
Endomyocardial Biopsy Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Forceps | 135.22 | 144.61 | 154.53 | 168.22 | 180.09 | 194.18 | 207.87 | 222.12 | 239.11 | 258.45 |
| Accessories | 267.27 | 288.07 | 310.60 | 331.79 | 357.42 | 383.65 | 413.29 | 445.63 | 478.72 | 513.22 |
Endomyocardial Biopsy Market Size By Tip 2025 to 2034 (USD Billion)
| Tip | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Maxi-curved | 40.83 | 43.28 | 46.50 | 50.70 | 53.88 | 58.15 | 62.10 | 67.70 | 72.56 | 78.09 |
| Straight | 80.43 | 86.52 | 93.21 | 100.11 | 107.42 | 115.31 | 124.34 | 133.70 | 143.77 | 154.77 |
| Pre-curved | 120.51 | 130.06 | 139.35 | 149.44 | 161.73 | 173.51 | 186.77 | 200.20 | 215.16 | 231.42 |
| Others | 160.71 | 172.81 | 186.06 | 199.75 | 214.48 | 230.85 | 247.96 | 266.15 | 286.34 | 307.39 |
Endomyocardial Biopsy Market Size By End-use 2025 to 2034 (USD Billion)
| End-use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 67.58 | 72.29 | 78.45 | 83.15 | 89.40 | 96.06 | 104.32 | 111.46 | 120.04 | 130.18 |
| Ambulatory Surgical Centers | 134.51 | 144.06 | 155.12 | 166.69 | 179.25 | 192.64 | 207.65 | 222.51 | 238.74 | 256.20 |
| Others | 200.40 | 216.33 | 231.56 | 250.16 | 268.86 | 289.13 | 309.20 | 333.78 | 359.05 | 385.29 |
Endomyocardial Biopsy Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 40.64 | 43.92 | 46.56 | 50.69 | 54.32 | 58.43 | 62.54 | 67.63 | 72.70 | 77.58 |
| LAMEA | 80.23 | 86.44 | 92.96 | 99.96 | 107.36 | 116.00 | 124.17 | 133.53 | 143.17 | 154.97 |
| Europe | 120.78 | 129.52 | 139.64 | 149.60 | 160.97 | 172.95 | 186.56 | 200.42 | 215.55 | 231.26 |
| Asia-Pacific | 160.85 | 172.80 | 185.98 | 199.75 | 214.86 | 230.44 | 247.89 | 266.18 | 286.42 | 307.86 |
Endomyocardial Biopsy Market Size to Hit USD 771.67 Million by 2034
The global endomyocardial biopsy market size is evaluated at USD 402.49 million in 2025 and is expected to grow around USD 771.67 million by 2034 with a registering a CAGR of 7.50%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com